Allergic Rhinitis Market To Develop Worth To USD 18.02 Billion By 2030

Pune, India, October, 2022/press release/- Market Research Future Published a Half-Cooked Research Report on Allergic Rhinitis Market Research Report.

Market Highlights

The global Allergic Rhinitis Market is accounted to register a CAGR of 3.30% during the forecast period and is estimated to reach USD 18.02 billion by 2030.

The allergic rhinitis market refers to the pharmaceutical and healthcare industry related to the diagnosis, treatment, and management of allergic rhinitis, also known as hay fever. Allergic rhinitis is a common condition characterized by inflammation of the nasal passages due to an immune response triggered by allergens such as pollen, dust mites, pet dander, or mold.

Segment Analysis

The global Allergic Rhinitis Market has been segmented based on Type, Treatment, and Route of Administration.

The allergic rhinitis market segmentation, based on type, includes seasonal allergic rhinitis, perennial allergic rhinitis, and occupational allergic rhinitis. The seasonal Allergic Rhinitis segment held the majority share in 2021 in respect to the allergic rhinitis market revenue. This is primarily owing to the rising awareness about allergic rhinitis and high usage of tobaccoacross the globe. Pollen is the most common allergen in seasonal allergic rhinitis. Mold, animal dander, and dust are the other substances that can cause allergic rhinitis.

The market segments of allergic rhinitis, based on treatment, includes Antihistamines, Corticosteroids, Immunotherapy, Decongestants and others. The Antihistamines segment dominated the market in 2021 and is projected to be the faster-growing segment during the forecast period, 2022-2030. Antihistamines drugs help in the treatment of allergic rhinitis and other allergies. People take antihistamines as inexpensive, generic, over-the-counter drugs that can give relief from nasal congestion, and sneezing. Hence, rising applications of Antihistamines treatment for Allergic Rhinitis positively impacts the market growth.

The market of allergic rhinitis has been bifurcated by Route of Administration into Oral, and Nasal & Others. The nasal & other route of administration segment dominated the market in 2021 and is projected to be the faster-growing segment during the forecast period, 2022-2030. The market is estimated to grow owing to the quality of drugs and nasal sprays manufactured by manufacturers for the effective treatment of allergic rhinitis.

Explore In-depth Market Details [Table of Content, List of Figures, List of Tables] of Allergic Rhinitis Market Research Report

Regional Analysis

The global Allergic Rhinitis Market, based on region, has been divided into North America, Europe, Asia-Pacific and Rest of the World. North America Allergic Rhinitis market accounted for USD 6.0048 billion in 2021 and is expected to exhibit a significant CAGR growth during the study period. This is attributed to the large amount of R&D expenditure for the development of allergy treatment across the region. Further, the major countries studied in the market report are: The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Europe market of allergic rhinitis accounts for the one of the largest market share due to the established healthcare system, high medical expenditure, access to advanced treatment solutions, demand for preventive care by diagnostic examinations, research funding for early treatment options, and higher awareness of allergic rhinitis. Further, the Germany market of allergic rhinitis held the largest market share, and the UK market of allergic rhinitis was the fastest growing market in the European region

The Asia-Pacific market of allergic rhinitis is expected to grow at the fastest CAGR from 2022 to 2030. This is due to the rising healthcare expenditure and high disposable income. High demand of advance technology and high prevalence of respiratory disease are fuelling the market growth of Allergic Rhinitis Drugs in the region. Moreover, China Allergic market of allergic rhinitis held the largest market share, and the India market of allergic rhinitis was the fastest growing market in the Asia-Pacific region.

Key Findings of the Study

• The global Allergic Rhinitis Market is expected to reach USD 18.02 billion by 2030, at a CAGR of 3.30% during the forecast period.


• The Asia-Pacific market of allergic rhinitis is expected to grow at the fastest CAGR from 2022 to 2030. This is due to the rising healthcare expenditure and high disposable income.


• The allergic rhinitis market segmentation, based on type, includes seasonal allergic rhinitis, perennial allergic rhinitis, and occupational allergic rhinitis.


• AstraZeneca, GlaxoSmithKline plc, Johnson & Johnson Services, Glenmark and others